Currently, there is no FDA-approved indication for GLP-1 receptor agonists or GIP/GLP-1 dual agonists specifically for lipedema treatment, and high-quality clinical trial evidence remains limited
Beyond fat metabolism, the research on LCLT covers exercise recovery (multiple studies documenting reduced muscle damage markers and accelerated recovery between training sessions), androgen receptor upregulation (increasing the density of testosterone receptors in muscle tissue, improving the anabolic response to training), and reduced exercise-induced oxidative stress
Doing so may allow specific compounds to be extracted or to produce an extract without the hydrolysis of cell contents (as in autolysis) happening
The appetite suppression provides a window of opportunity to establish sustainable habits
Tirzepatide, sold as Mounjaro, is also primarily a diabetes treatment
cisplatin, docetaxel) is associated with the activation of p38 MAPK-mediated growth suppression